Lupin to co-market Novartis’ asthma drug in India

BS B2B Bureau  |  Mumbai April 12, 2016 Last Updated at 10:27 IST

Novartis Healthcare will continue to market Sequadra (indacaterol/glycopyrronium inhaler), while Lupin will promote the inhaler under the brand name Loftair in India

read original article at

http://www.business-standard.com/content/b2b-pharma/lupin-to-co-market-novartis-asthma-drug-in-india-116041200249_1.html